Normal Delivery (Vaginal Birth) — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Normal delivery, or vaginal birth, is the physiological process by which a baby is born through the birth canal (vagina) without recourse to caesarean section, and without major complications requiring emergency operative intervention. It is the natural and preferred mode of delivery for healthy pregnancies — recommended by the World Health Organization, NICE, ACOG, and all major international obstetric bodies for women without obstetric contraindications. Globally, approximately 70–80% of all births occur vaginally, though this proportion varies considerably by country, healthcare system, and practice patterns. Labour progresses through three clinically defined stages. The first stage — the longest — spans from the onset of regular, painful contractions causing progressive cervical change to full cervical dilatation of 10 cm; it is further divided into a latent phase (contractions begin, cervix effaces and dilates slowly to 6 cm, lasting 8–20 hours in first-time mothers) and an active phase (rapid cervical dilation from 6–10 cm, typically 1–2 cm per hour). The second stage begins at full dilatation and ends with birth of the baby, lasting 30 minutes to 3 hours. The third stage begins after birth and ends with delivery of the placenta, lasting 5–30 minutes with active management. Labour is supported by a dedicated midwife providing continuous one-to-one care, with obstetrician involvement for any deviation from normal progress. Pain management, electronic fetal monitoring (CTG — cardiotocography), and surveillance for obstetric emergencies (cord prolapse, shoulder dystocia, postpartum haemorrhage) are core components of skilled intrapartum care.

Vaginal delivery is recommended for all uncomplicated singleton pregnancies in which the baby is in cephalic (head-down) presentation with an adequate maternal pelvis, and in which no medical or obstetric contraindications exist. It is also the recommended mode of birth for selected women with complications when vaginal delivery is clinically appropriate and safe. Previous caesarean section does not automatically preclude vaginal birth: vaginal birth after caesarean (VBAC) is safe and successful in 60–80% of appropriately selected women with one prior lower-uterine-segment caesarean section, with a uterine rupture risk of approximately 0.5% — lower than the surgical and anaesthetic risks of a planned repeat caesarean in many women. VBAC eligibility requires discussion with an obstetrician, continuous intrapartum CTG monitoring, and delivery in a unit with immediate access to emergency caesarean and neonatal resuscitation. Contraindications to planned vaginal delivery include: placenta praevia major (placenta covering the cervical os); active primary genital herpes infection at onset of labour (caesarean section required within 4 hours of membrane rupture); umbilical cord prolapse (emergency caesarean); brow or transverse lie presentation; confirmed or suspected cephalopelvic disproportion; previous classical (vertical) uterine scar or more than two prior lower-segment caesarean sections; certain placenta accreta spectrum disorders; and specific fetal conditions including monochorionic monoamniotic twins and some cases of fetal compromise requiring immediate delivery. All decisions about mode of birth are made jointly between the mother and her obstetric team, ideally in the antenatal period, with full information about risks and benefits of vaginal and caesarean birth for the specific clinical situation.

On admission to the labour ward, fetal wellbeing is assessed with CTG (electronic fetal monitoring) and maternal observations recorded. Membranes may rupture spontaneously (waters breaking) or be artificially ruptured (ARM — amniotomy) by the midwife to accelerate labour progress when appropriate. If labour requires augmentation — because progress has stalled — an intravenous oxytocin (Syntocinon) infusion is commenced at a low dose and titrated upward at 30-minute intervals until three to four adequate contractions occur per 10 minutes, with continuous CTG monitoring. Pain management options include: Entonox (50:50 nitrous oxide and oxygen gas mixture, inhaled through a mouthpiece at the onset of each contraction) — effective mild-to-moderate analgesia with rapid onset and offset; intramuscular opioids (pethidine 100 mg or diamorphine 5–7.5 mg) — more effective analgesics but cause maternal sedation and can affect the baby's breathing at birth, requiring neonatal resuscitation readiness; epidural analgesia — a catheter placed in the epidural space of the lumbar spine delivers a continuous infusion of low-dose local anaesthetic (bupivacaine 0.0625–0.1%) and opioid (fentanyl), providing the most effective labour pain relief (80–90% report excellent analgesia) without affecting the baby, but may slow second-stage progress slightly and requires additional monitoring; and combined spinal-epidural (CSE) for faster onset epidural analgesia. During the second stage, the mother adopts a comfortable position for pushing — semi-recumbent, lateral, kneeling, or on all fours — and pushes with uterine contractions, guided by midwifery support. The fetal head descends through the pelvis and crowns at the perineum. Controlled delivery of the head, followed by delivery of the anterior shoulder under gentle traction, and then the posterior shoulder and body, complete the birth. An episiotomy — a surgical incision in the perineum to widen the vaginal opening — is performed selectively when there is a risk of severe perineal tearing or fetal distress requiring rapid delivery; routine episiotomy is not recommended. Active management of the third stage — an intramuscular or intravenous oxytocin injection immediately after the baby's birth — reduces the risk of postpartum haemorrhage by 60% and is recommended for all women unless specifically declined. The placenta is delivered by controlled cord traction with uterine counter-pressure. Any perineal tears or episiotomy are sutured under local anaesthetic.

Vaginal birth offers substantial advantages over caesarean section for both mother and baby that are consistent across large observational studies and meta-analyses. Maternal recovery is significantly faster: most women who deliver vaginally are mobile within hours, discharged within 24–48 hours, and fully physically recovered within 4–6 weeks. In contrast, caesarean section requires 2–4 day hospital stay, 6–8 weeks of wound recovery, and carries the risks of major abdominal surgery including haemorrhage, visceral injury, and wound complications. Vaginal birth avoids the lifelong risks associated with a uterine scar — increased risk of uterine rupture, placenta praevia, and placenta accreta in future pregnancies — which escalate with each successive caesarean section. For the baby, passage through the vaginal canal during birth provides exposure to maternal vaginal and perineal microbiota that colonises the infant gut, establishing a healthy microbiome in the first days of life; this microbiome priming is associated with reduced rates of asthma, allergy, obesity, and type 1 diabetes in later life compared with caesarean-born infants. Respiratory morbidity — transient tachypnoea of the newborn (TTN) — is significantly more common after elective caesarean section (3–5%) than after vaginal birth (0.5–1%), because the physical compression of the thorax during vaginal birth squeezes fetal lung fluid out of the airways. Breastfeeding initiation rates are higher after vaginal birth, partly due to faster maternal recovery and earlier skin-to-skin contact. Oxytocin released during labour and birth promotes mother-infant bonding. WHO recommends that caesarean section rates at the population level should not exceed 10–15% — rates above this are not associated with further improvements in maternal or neonatal outcomes.

While vaginal birth is the safest mode of delivery for most women and babies, it is not without risk. Postpartum haemorrhage (PPH) — defined as blood loss greater than 500 mL after vaginal birth — occurs in 3–5% of deliveries; major PPH (blood loss over 1 litre) occurs in 1–2%. Active management of the third stage with routine oxytocin administration has substantially reduced PPH rates. Causes include uterine atony (most common), retained placenta, and perineal lacerations. Management uses uterotonic agents (oxytocin, misoprostol, carbetocin), bimanual uterine compression, tranexamic acid, and surgical or radiological haemostatic procedures for refractory cases. Perineal trauma — lacerations of the vaginal wall and perineum — occurs to varying degrees in most first-time mothers: first degree (superficial skin only) in approximately 45%, second degree (skin and perineal muscle) in 40%, third degree (involving the external anal sphincter) in 2–4%, and fourth degree (involving the anal sphincter and rectal mucosa) in under 1%. Third and fourth degree tears (obstetric anal sphincter injuries — OASIS) require specialist repair in theatre under spinal or general anaesthesia and carry a risk of long-term faecal incontinence in 20–30% of affected women. Instrumental delivery (forceps or ventouse vacuum extraction) is required in 10–15% of labours when progress stalls in the second stage or when there is fetal distress requiring immediate assisted delivery. Emergency caesarean section is required in 5–10% of planned vaginal deliveries. Neonatal distress requiring resuscitation occurs in approximately 2–3%, usually resolving with brief interventions including oxygen, bag-mask ventilation, or chest compressions. Intrapartum fetal hypoxia causing neonatal encephalopathy occurs in approximately 1–2 per 1,000 births and is a serious complication managed by therapeutic hypothermia (cooling) for 72 hours. Continuous CTG monitoring in high-risk labours and skilled midwifery surveillance minimise but do not eliminate these risks.

Immediately after delivery, the mother is monitored for 1–2 hours for vital signs, uterine tone (to detect early PPH), and bladder function. The baby is placed skin-to-skin on the mother's chest immediately after birth to promote bonding, regulate temperature, and initiate breastfeeding within the first hour — recommended by UNICEF Baby Friendly Initiative guidelines. Perineal tears and episiotomy wounds are sutured with rapidly dissolving sutures (Vicryl Rapide) that do not require removal. Perineal pain and swelling are managed with regular paracetamol, ibuprofen (if not breastfeeding or if appropriate), ice packs for the first 24–48 hours, and warm sitz baths. Constipation — particularly painful with perineal wounds — is prevented with laxatives (lactulose, movicol) and a high-fibre diet. Most women are mobile within 2–6 hours of delivery and are encouraged to mobilise early to prevent DVT. A physiotherapist provides pelvic floor exercise guidance — beginning pelvic floor (Kegel) exercises from day 1 is recommended to restore continence and prevent prolapse, starting gently and increasing progressively. Hospital discharge occurs at 24–48 hours for uncomplicated vaginal birth. Community midwife visits occur on days 1, 3, 5, and 10 to support breastfeeding, assess wound healing, and monitor for signs of infection, perineal complications, or postnatal depression. Full perineal wound healing takes 2–3 weeks. Resumption of sexual intercourse is typically deferred until perineal healing is complete — usually 6 weeks, though many women find longer intervals more comfortable. A 6-week postnatal check with the GP assesses maternal physical and emotional wellbeing, contraception, and referral for pelvic floor physiotherapy if incontinence or prolapse symptoms persist. Return to exercise — walking from week 1, low-impact activity from week 6, running and high-impact exercise from 12 weeks after pelvic floor assessment — is individually guided.